CAREONE MAXIMUM REDNESS RELIEF EYE DROPS- glycerin and naphazoline hydrochloride liquid
Retail Business Services, LLC
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Naphazoline HCI 0.03%
- for the relief of redness of the eye due to minor eye irriatations
- for the temporary relief of burning and irritation due to dryness of the eye
- for use as a protectant against further irritation or dryness of the eye
For external use only
if solution changes color or becomes cloudy
narrow angle glaucoma
- to avoid contamination, do not touch tip of container to any surface
- replace cap after using
- overuse may produce increased redness of the eye
- pupils may become enlarged temporarily
- you experience eye pain
- you experience changes in vision
- you experience continued redness or irritation of the eye
- the condition worsens or persists for more than 72 hours
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
instill 1 or 2 drops in the affected eye(s) up to 4 times daily.
- store at room temperature
- remove contact lenses before using
benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate
| CAREONE MAXIMUM REDNESS RELIEF EYE DROPS |
glycerin, naphazoline hci liquid
|Labeler — Retail Business Services, LLC (967989935)|
|Registrant — KC Pharmaceuticals, Inc. (174450460)|
|KC Pharmaceuticals, Inc.||174450460||manufacture (72476-012), pack (72476-012), label (72476-012)|
Revised: 01/2020 Retail Business Services, LLC
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.